Anzeige
Meldung des Tages: Breaking News: “Königs-Exosomen” senken Entzündungslevel um 90%…
Neuester,
zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter
... 101 102 104 105 ...
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter ... 101 102 104 105 ...
Biophan-die neue Microsoft?!
Beiträge:
2.825
Zugriffe: 460.531 / Heute: 4
Zugriffe: 460.531 / Heute: 4
|
| ||||||||||||||
Werbung
Entdecke die beliebtesten ETFs von SPDR
Da könnt ihr jetzt freuen, supi ;-)9
Weiter so ;-)
Weiter so ;-)
auch mal für meine Aktie ,... träum ;-)
dich trifft man ja auch überall. Drück uns mal die Daumen das es wieder upppp geht.
Greetz sweden
Greetz sweden
so gut ging der kurs ja heute nicht...erst rauf auf 0,22...dann runter bis auf unter 0,18 runter.
Wenn das mal nicht...volatil ist, dann weiß ich es nicht.
immerhin auch ein minus von zwanzig prozent am Tag....
Wenn das mal nicht...volatil ist, dann weiß ich es nicht.
immerhin auch ein minus von zwanzig prozent am Tag....
aber immer noch 30% Plus, wenn du dabei warst.
Morgen ist ein neuer Tag und dann wollen wir doch mal sehen.
Morgen ist ein neuer Tag und dann wollen wir doch mal sehen.
buran,du lebst ja noch schön dich zu lesen...und nun??du weist schon...
Patente werden für 11 Mio. an Medtronic verkauft. Genauer Wortlaut bei WO!
Medtronic to Acquire Biophan MRI Safety Technology for $11 Million
PITTSFORD, NY -- (MARKET WIRE) -- 08/09/07 -- Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced that the Company has entered into a definitive agreement with Medtronic, Inc. (NYSE: MDT) to acquire Biophan's MRI safety patents in a transaction worth $11 million in cash. The transaction is anticipated to close within 60 days.
Under the terms of the agreement, Biophan will transfer to Medtronic its MRI safety patent portfolio, which includes technologies that make medical devices, such as pacemakers, safe for use with MRI.
"Since our founding in 2000, our goal has been to develop and commercialize innovative technologies related to medical imaging safety, with a focus on the development of solutions for the contraindication between pacemakers and MRI machines," stated Mr. Guenter Jaensch, Chairman of Biophan's Board of Directors.
"Our technology has the potential to solve the problems that have prevented many people with pacemakers from having an MRI. We believe Medtronic has the experience and resources to bring our technology to market," stated Michael Weiner, President of Biophan.
Biophan will continue its efforts to develop technologies to enable visualization of clotting and restenosis in stents under MRI, which is not possible with today's stents. In addition, it will continue its collaboration with Myotech on the development of the Myotech Circulatory Support System, a novel device for the treatment of acute heart failure.
About Biophan Technologies, Inc.:
Biophan is dedicated to providing technologies that offer innovative and competitive advantages to the medical device industry. In addition, the Company is helping to commercialize Myotech's new cardiac support system which has significant potential to improve the treatment of many forms of heart disease. Biophan Technologies, Inc. holds a 45% interest in Myotech with rights to acquire a majority position, and is leading Myotech's business development efforts. Biophan is traded on the OTC market under the symbol BIPH, and is also listed on the Frankfurt Stock Exchange under the symbol BTN. For more information on Biophan, please visit our website at www.biophan.com.
PITTSFORD, NY -- (MARKET WIRE) -- 08/09/07 -- Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced that the Company has entered into a definitive agreement with Medtronic, Inc. (NYSE: MDT) to acquire Biophan's MRI safety patents in a transaction worth $11 million in cash. The transaction is anticipated to close within 60 days.
Under the terms of the agreement, Biophan will transfer to Medtronic its MRI safety patent portfolio, which includes technologies that make medical devices, such as pacemakers, safe for use with MRI.
"Since our founding in 2000, our goal has been to develop and commercialize innovative technologies related to medical imaging safety, with a focus on the development of solutions for the contraindication between pacemakers and MRI machines," stated Mr. Guenter Jaensch, Chairman of Biophan's Board of Directors.
"Our technology has the potential to solve the problems that have prevented many people with pacemakers from having an MRI. We believe Medtronic has the experience and resources to bring our technology to market," stated Michael Weiner, President of Biophan.
Biophan will continue its efforts to develop technologies to enable visualization of clotting and restenosis in stents under MRI, which is not possible with today's stents. In addition, it will continue its collaboration with Myotech on the development of the Myotech Circulatory Support System, a novel device for the treatment of acute heart failure.
About Biophan Technologies, Inc.:
Biophan is dedicated to providing technologies that offer innovative and competitive advantages to the medical device industry. In addition, the Company is helping to commercialize Myotech's new cardiac support system which has significant potential to improve the treatment of many forms of heart disease. Biophan Technologies, Inc. holds a 45% interest in Myotech with rights to acquire a majority position, and is leading Myotech's business development efforts. Biophan is traded on the OTC market under the symbol BIPH, and is also listed on the Frankfurt Stock Exchange under the symbol BTN. For more information on Biophan, please visit our website at www.biophan.com.
bitte mal zünden....
normaler Weise ist dafür high master zuständig...:-)..wo auch immer er ist...
also bitte starten..:-)
normaler Weise ist dafür high master zuständig...:-)..wo auch immer er ist...
also bitte starten..:-)
Ein super Nachricht heute. Mal schauen wie hoch es heute noch geht.
Denke 0,30 sind heute drin
Denke 0,30 sind heute drin
die news haben wohl nicht geholfen, den Kurs zu halten..bzw. hochzuziehen...
die ,die den Ernst der Lage nicht kapiert haben ,positiv gesehen natürlich :-)
die Schlauen, verlassen das Schiff....
wie man es sieht..:-)..
denn was kommen denn jetzt noch für news?...
wie man es sieht..:-)..
denn was kommen denn jetzt noch für news?...
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem Biophan Technologies Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
6 | 2.824 | Biophan-die neue Microsoft?! | aida73 | MrTrillion3 | 26.07.23 00:01 | |
| 5 | 50 | Lauert hier ein starker Kursanstieg? | Superflach | CosmicTrade | 22.11.08 23:06 | |
| 83 | WKN 541861 Sofort auf die Watch | plusquamperfekt | shaq | 08.08.07 22:44 | ||
| 1 | Das Wichtigste: | cogito,ergo sum | cogito,ergo sum | 22.03.07 13:33 |